Therefore, the hypoxic state following anti-angiogenic therapy may stimulate HIF-1α, which, in turn, activates VEGF-independent angiogenetic pathways, including FGF/FGFR, promoting tumor revascularization and, eventually, tumor progression. Here, HIF1A is linked to neoplasm.